1) Reading The Cuozzo Tea Leaves: Best
Practices Pending The Supreme Court's
Decision
By Stephen B. Maebius and Eley O. Thompson
27 April 2016
PTAB Trial Insights
The Supreme Court of the United States heard oral argument today on claim construction in inter
partes review (IPR) proceedings and the reviewability of institution decisions (a copy of the petition
for certiorari is reported at “Supreme Court Accepts 1st IPR Appeal: Cuozzo Could Mark Turning
Point for Patent Owners”). On the claim construction issue, the Justices seemed to struggle with the
tension between IPRs being consistent with validity determinations in district court litigation, or
patentability determinations in USPTO proceedings, referencing them several times as “hybrid”
proceedings. Given the uncertainty of the outcome on both appealed questions (whether broadest
reasonable interpretation will be retained and whether decisions to institute can be appealed),
practitioners should take steps in pending proceedings to protect their rights under the different
outcomes.
Comments from the Justices
As Justice Kennedy noted, “if the patent is invalid under its broadest, reasonable interpretation
doesn’t – doesn’t that mean that the PTO should never have issued the patent in the first place..?”
Tr. 11. The implication of the question was that applying a district court standard would require the
USPTO to put its stamp of approval on patents it would not have issued.
In the context of litigation where IPRs often arise, Chief Justice Roberts observed that “it’s a very
extraordinary animal in legal culture to have two different proceedings addressing the same
question that lead to different results.” Tr. 32. Chief Justice Roberts further commented that “[i]t just
seems to me that that’s a bizarre way to conduct legal – decide a legal question.” Tr. 41.
Justice Alito did not seem to be as troubled about differences between IPRs and district court
proceedings when he asked “is the standard of proof for invalidity the same in an infringement
action in the district court as it is in inter partes review?” Tr. 6-7. The answer of course is that the
standards are different by statute. Justice Breyer drew the contrast characterizing IPRs potentially
as “a partial Ground-Hog Day statute” or a “little district court proceeding.” Tr. 37-38.
Justice Ginsburg observed that IPRs were a “[k]ind of hybrid. It has – in certain respects it
resembles administrative proceedings and other district court proceedings.” Tr. 23. Attempting to
bring the two interpretation standards together, Justice Sotomayer observed, “[s]o how different at
the end of that [examination] process is the ordinary meaning from a continuing broad meaning?
You’ve already had all these chances to amend, to make things as precise and as narrow as the
Patent Office thinks it needs to be.” Tr. 27.
2) Justice Kagan took the approach of looking at the issue from the perspective of Congress noting,
“if I’m trying to put myself in Congress’s position, I’m – I’m looking at the PTO, and it does pretty
much everything by this broadest-construction standard. And if I had the clear intent that you’re
suggesting, given the backdrop of how the PTO generally operates, wouldn’t I say so?” Tr. 22.
Justice Breyer commented that “[i]f it’s ambiguous between those two purposes, I would begin to
think, well, maybe they [USPTO] should have the power themselves under Chevron, Meade, or
whatever, to decide which to do.” Tr. 15.
While it was unclear how the court will ultimately rule, it was rather clear that the biggest proponent
for consistency with the district court proceedings was Chief Justice Roberts and the biggest
proponent of the USPTO being able to recall patents under their own BRI standard was debatable
because several Justices seemed to support the notion.
Less Time Spent on Appealability Of Institution Decisions
Very little time was spend on the reviewability issue. Justice Sotomayor observed about legal
precedent that “we don’t easily think that Congress is intending to prevent courts from enforcing its
directives to Federal agencies, okay?” Tr. 49 Justice Sotomayor asked, “[w]hy would Congress tell
the PTO don’t do it except in these limited circumstances, but nobody’s going to ever watch you to
make sure that’s what you’re doing?” Tr. 50
Best Practices While Awaiting The Decision
Given the uncertainty, parties should lay out their positions in their filings to reflect possible
outcomes for both issues. Indeed, at recent oral hearings, some AJPs have asked the parties to
explain if elimination of BRI would change the outcome, so the Board is already seeking to have the
record clear in the event of a change in the standard for claim construction. See, e.g., final hearing
transcript in IPR2015-00291. Parties should prepare for such lines of questioning and be ready to
articulate their claim construction under either broadest reasonable interpretation or ordinary
construction, and explain how they would prevail under both standards. Alternatively, if they have a
case where they believe the same construction applies under both standards, they can be
prepared to respond in that way.
For appealability, if a party believes there is an incorrect decision to institute, they have the option
of setting forth their position in their patent owner response. However, absent a reversal on this
issue, the only available option for challenging an institution decision appears to be a mandamus
petition to the Federal Circuit immediately after an institution decision, which is a request for
extraordinary relief. This route is very difficult because it requires a showing by a petitioner “(1) that
it has a clear legal right to relief; (2) that there are no adequate alternative legal channels through
which petitioner may obtain that relief; and (3) that the grant of mandamus is appropriate under the
circumstances.” See In re MCM Portfolio (Fed. Cir. 2014).